Efficacy and tolerability of aripiprazole: A 26-week switching study from oral antipsychotics

Keyphrases

• Tolerability 100%
• Aripiprazole 100%
• Oral Antipsychotics 100%
• Switching Study 100%
• Confidence Interval 25%
• Remission 25%
• Clinical Global Impression 25%
• Headache 8%
• Insomnia 8%
• Adverse Events 8%
• Nausea 8%
• Schizophrenia 8%
• Antipsychotics 8%
• Patients with Schizophrenia 8%
• Stable Patients 8%
• Treatment-related Adverse Events 8%
• Aggravation 8%
• Remission Rate 8%
• Severity Score 8%
• Effectiveness Analysis 8%
• Schizophrenia Symptoms 8%
• Schizoaffective Disorder 8%
• Negative Syndrome 8%
• Gender Distribution 8%
• Clinically Stable 8%
• Maintenance Performance 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Tolerability 100%
• Typical Antipsychotic 100%
• Aripiprazole 100%
• Remission 33%
• Adverse Event 16%
• Headache 8%
• Nausea 8%
• Positive Syndrome 8%
• Negative Syndrome 8%
• Schizoaffective Psychosis 8%

Medicine and Dentistry

• Typical Antipsychotic 100%
• Aripiprazole 100%
• Clinical Global Impression 25%
• Adverse Event 16%
• Outpatient 8%
• Spontaneous Remission 8%
• Nausea 8%
• Headache 8%
• Schizoaffective Disorder 8%
• Positive and Negative Syndrome Scale 8%